Search research articles
Contact Us
Filters
Showing results (361-370 of 445) with videos related to
Page
of 45
Sort By:
Viruses
|
January 22, 2022
Photodynamic Inactivation of Human Coronaviruses
Brett A Duguay, Adrian Herod, Eric S Pringle, et al.
Photochemistry and Photobiology
|
December 9, 2022
Establishing a Robust and Reliable Response from a Potent Osmium-Based Photosensitizer Via Lipid Nanoformulation<sup>†</sup>
Houston D Cole, Menitte Eroy, John A Roque, et al.
Annals of Internal Medicine
|
March 1, 1990
Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy
M A Flowers, J Heathcote, I R Wanless, et al.
American Journal of Cancer Research
|
February 10, 2022
Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell death
Prathyusha Konda, John A Roque Iii, Liubov M Lifshits, et al.
Journal of Toxicology. Clinical Toxicology
|
January 1, 1996
Efficacy of deferiprone in the treatment of acute iron intoxication in rats
F F Fassos, M Berkovitch, N Daneman, et al.
Chemical Science
|
March 19, 2021
Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy
Deborah A Smithen, Susan Monro, Mitch Pinto, et al.
Journal of Medicinal Chemistry
|
October 14, 2005
Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor
David R Coleman, Zhiyong Ren, Pijus K Mandal, et al.
Pediatric Hematology and Oncology
|
July 17, 1999
The total care unit for pediatric hematology and oncology, Princess Margaret Hospital for Children, Perth, Australia
C H Cole, M L Willoughby, F G Cameron, et al.
Toxicology and Applied Pharmacology
|
September 15, 1990
Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1
B A Quinn, T L Crane, T E Kocal, et al.
Psychosomatic Medicine
|
July 1, 1996
Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives
O G Cameron, C B Smith, R M Nesse, et al.
Page
of 45
Search research articles
Search
Showing results (361-370 of 445) with videos related to
Sort By:
Page
of 45
Viruses
|
January 22, 2022
Photodynamic Inactivation of Human Coronaviruses
Brett A Duguay, Adrian Herod, Eric S Pringle, et al.
Photochemistry and Photobiology
|
December 9, 2022
Establishing a Robust and Reliable Response from a Potent Osmium-Based Photosensitizer Via Lipid Nanoformulation<sup>†</sup>
Houston D Cole, Menitte Eroy, John A Roque, et al.
Annals of Internal Medicine
|
March 1, 1990
Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy
M A Flowers, J Heathcote, I R Wanless, et al.
American Journal of Cancer Research
|
February 10, 2022
Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell death
Prathyusha Konda, John A Roque Iii, Liubov M Lifshits, et al.
Journal of Toxicology. Clinical Toxicology
|
January 1, 1996
Efficacy of deferiprone in the treatment of acute iron intoxication in rats
F F Fassos, M Berkovitch, N Daneman, et al.
Chemical Science
|
March 19, 2021
Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy
Deborah A Smithen, Susan Monro, Mitch Pinto, et al.
Journal of Medicinal Chemistry
|
October 14, 2005
Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor
David R Coleman, Zhiyong Ren, Pijus K Mandal, et al.
Pediatric Hematology and Oncology
|
July 17, 1999
The total care unit for pediatric hematology and oncology, Princess Margaret Hospital for Children, Perth, Australia
C H Cole, M L Willoughby, F G Cameron, et al.
Toxicology and Applied Pharmacology
|
September 15, 1990
Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1
B A Quinn, T L Crane, T E Kocal, et al.
Psychosomatic Medicine
|
July 1, 1996
Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives
O G Cameron, C B Smith, R M Nesse, et al.
Page
of 45